Remarkable polymorphism of HLA-B27: an ongoing saga

Area of Science:

• Immunogenetics
• Rheumatology
• Molecular Biology

Background:

• The human leukocyte antigen (HLA)-B27 gene is a well-established risk factor for ankylosing spondylitis (AS) and related spondyloarthropathies.
• Despite its strong association, the precise biological mechanisms linking HLA-B27 to these inflammatory conditions remain largely unknown.

Observation:

• HLA-B27 is a diverse gene family with numerous alleles and protein subtypes.
• There are 75 known HLA-B27 alleles based on DNA sequences and 62 distinct protein subtypes.
• The prevalence of HLA-B27 varies globally.

Findings:

• Not all HLA-B27 subtypes are equally associated with AS and related diseases.
• A potential hierarchical ranking exists among certain HLA-B27 subtypes concerning their disease association.
• The specific subtypes and their varying disease associations are critical for understanding pathogenesis.

Implications:

• Further research into specific HLA-B27 subtypes may elucidate the pathogenesis of spondyloarthropathies.
• Identifying disease-associated subtypes could lead to more targeted diagnostic or therapeutic strategies.
• Understanding the genetic heterogeneity of HLA-B27 is crucial for personalized medicine approaches in rheumatology.